Sijo Chemmannur
About Sijo Chemmannur
Sijo Chemmannur is a Formulation Scientist II at Precision NanoSystems Inc. in Vancouver, British Columbia, with over 10 years of research experience in molecular biology, cancer research, and immunology.
Current Role at Precision NanoSystems
Sijo Chemmannur serves as a Formulation Scientist II at Precision NanoSystems Inc., a position he has held since 2020. Based in Vancouver, British Columbia, Canada, he focuses on the development of formulations in the biotechnology sector. His role involves applying his extensive knowledge in molecular biology and immunology to create innovative solutions for drug delivery systems.
Previous Experience at Fox Chase Cancer Center
Prior to his current role, Sijo worked as a Postdoctoral Research Associate at Fox Chase Cancer Center from 2016 to 2020. During his four years in Philadelphia, he contributed to cancer research projects, leveraging his expertise in molecular biology and immunology to advance scientific understanding in the field.
Postdoctoral Research at UPMC
Sijo Chemmannur was a Postdoctoral Researcher at UPMC from 2014 to 2016. His two years in Pittsburgh, Pennsylvania, involved conducting research that furthered his knowledge and experience in molecular biology and cancer research, building on his academic background.
Educational Background in Immunology and Molecular Biology
Sijo earned his Doctor of Philosophy (PhD) in Immunology, Molecular Biology, and Cell Biology from the National Center for Cell Science, where he studied from 2008 to 2014. He also holds a Master of Science (MSc) in Biochemistry and Molecular Biology from Pondicherry University, completed between 2005 and 2007, and a Bachelor of Science (BS) in Biochemistry from the University of Calicut, obtained from 2002 to 2005.
Research Expertise in Molecular Biology and Cancer
With over 10 years of research experience, Sijo specializes in molecular biology, cancer research, and immunology. His comprehensive background in these areas enables him to contribute effectively to scientific advancements and innovative research initiatives.